Reprise Biomedical, Inc.
$117.0K 1,101 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Caldera Medical, Inc
Caldera Medical, Inc reported $117,091.97 across General Payments, Research, and Ownership to 1,085 physicians and teaching hospitals across 1,085 transactions.
- $117.1K Below-median payer
- All-tracks total
- 1,085 Above-median volume
- Transactions
- 1,085 Above-median reach
- Recipients
- −$76.5K
- General Payments vs PY2023
Caldera Medical, Inc reported $117,091.97 across all CMS Open Payments tracks (General + Research + Ownership) to 1,085 physicians and teaching hospitals in Program Year 2024 - ranking #1145 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $117,091.97, averaging $107.92 per recipient.
How Caldera Medical, Inc's $117.1K all-tracks total breaks down
Caldera Medical, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
21/100
Total payments
F
11/100
Transaction volume
F
18/100
Physician reach
F
18/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer caldera-medical-inc Caldera Medical, Inc
$117.1K · #1145/1,925 · 0.0% industry · PY2024
- TOT $117.1K
- RANK #1145
- SHARE 0.0%
- TXN 1,085
- RCP 1,085
- CAT 3
- GEN $117.1K
- ΔGEN −$76.5K
- TOP1 5.2%
- PY 2024
Volume peers
Nearest volume peer: Reprise Biomedical, Inc. ($117.0K)
Caldera Medical, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Caldera Medical, Inc's CMS-reported General Payments decreased by $76.5K (−39.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CALDERA MEDICAL, INCPY2023: CALDERA MEDICAL, INCPY2024: Caldera Medical, Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $193,630.74
- PY2024
- $117,091.97
What the Data Shows for Caldera Medical, Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Caldera Medical, Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
1,049 transactions worth $71.9K make "Food and Beverage" the top general-payment category in the 3-category breakdown below, 61.4% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 3 types of general payments, Caldera Medical, Inc's largest category was "Food and Beverage" at $71.9K - 61.4% of General Payments.
How Caldera Medical, Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $71.9K | 1,049 | 61.4% |
| Consulting Fee | $38.0K | 15 | 32.4% |
| Travel and Lodging | $7.2K | 21 | 6.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $28,573.22 (24.4%) of $117,091.97 in this company's General Payments records across 329 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Caldera Medical, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Richard Farnam
$6,102.73 across 25 reported transactions
- 2
Roger Dmochowski
$6,000.00 across 1 reported transactions
- 3
Paul Pettit
$5,600.00 across 2 reported transactions
- 4
Brent Parnell
$5,584.20 across 13 reported transactions
- 5
Megan Sneed
$5,286.29 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Caldera Medical, Inc ranks #1145 of 1,925 by total payments (bottom 41% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,583 of 1,838 by HHI (bottom 14% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Smoky Mountain Surgical Llc : $42.8K total payments, HHI 181
- Ascensia Diabetes Care Us Inc. : $258.2K total payments, HHI 181
- Conetic Solutions, Inc. : $36.7K total payments, HHI 180
- Pacira Pharmaceuticals Incorporated : $4.8M total payments, HHI 178
- Novo Nordisk AS : $2.4M total payments, HHI 178
- Omeza LLC : $1.5K total payments, HHI 178
- Caldera Medical, Inc (this company) : $117.1K total payments, HHI 177
- Karyopharm Therapeutics Inc. : $1.0M total payments, HHI 177
- Sagent Pharmaceuticals : $1.0K total payments, HHI 177
- Rigel Pharmaceuticals, Inc. : $1.0M total payments, HHI 175
- Servier Pharmaceuticals LLC : $1.5M total payments, HHI 174
- Mirati Therapeutics, Inc. : $322.0K total payments, HHI 171
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Caldera Medical, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Caldera Medical, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Caldera Medical, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Linde Gas & Equipment Inc.
$116.7K 348 recipients
Compare payment profiles
Jan Medical Inc.
$117.5K 6 recipients
Compare payment profiles
Brixton Biosciences, Inc.
$117.6K 72 recipients
Compare payment profiles
Ferring International Pharmascience Center US
$116.6K 3 recipients
Compare payment profiles
Forte Bio-Pharma LLC
$118.4K 5,751 recipients
Compare payment profiles
Put this to use
Caldera Medical, Inc ranks #1145 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Caldera Medical, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.